AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 8th, 2018 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on May , 2018 (the “Effective Date”).
May 8, 2018Loxo Oncology, Inc. • May 8th, 2018 • Pharmaceutical preparations • New York
On behalf of Loxo Oncology, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) is very pleased to offer you this amended and restated employment agreement (the “Agreement”):
